🏅 FDA Orphan Designation
Tegsedi
inotersen
Manufacturer: Ionis/AstraZeneca
Indicated for:
FDA-Approved Indications (1)
Hereditary ATTR amyloidosisOrphan Designation
Indicated for polyneuropathy of hATTR amyloidosis in adults.
Indications & Usage
Indicated for polyneuropathy of hATTR amyloidosis in adults.
💙 Support Programs
View all →Tegsedi
Ionis/AstraZeneca
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.